Advertisement
Home »

Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy Era.

May 01, 2023

ABOUT THE CONTRIBUTORS

  • Thinzar M Lwin

    Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA, USA.

    Zoey Kaelberer

    Division of Surgical Oncology, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA.

    Mengyuan Ruan

    Division of Surgical Oncology, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA.

    George Molina

    Division of Surgical Oncology, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA. GMOLINA@bwh.harvard.edu.

    Genevieve Boland

    Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement